Weight gain profiles of new anti-psychotics: public health consequences
- 1 August 2003
- journal article
- review article
- Published by Wiley in Obesity Reviews
- Vol. 4 (3) , 129-138
- https://doi.org/10.1046/j.1467-789x.2003.00105.x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Nucleus Accumbens Dopamine and the Regulation of Effort in Food-Seeking Behavior: Implications for Studies of Natural Motivation, Psychiatry, and Drug AbuseThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patientsJournal of Psychiatric Research, 2003
- Are Leptin and Cytokines Involved in Body Weight Gain during Treatment with Antipsychotic Drugs?The Canadian Journal of Psychiatry, 2002
- Changes in body mass index for individuals with and without schizophrenia, 1987–1996Schizophrenia Research, 2002
- Increased visceral fat distribution in drug-naive and drug-free patients with schizophreniaInternational Journal of Obesity, 2002
- Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medicationJournal of Psychiatric Research, 2001
- Body Mass Index in Persons with SchizophreniaThe Canadian Journal of Psychiatry, 2001
- Barriers to progress-the impact of tolerability problemsInternational Clinical Psychopharmacology, 2001
- The sympathetic nervous system and obesity: role in aetiology and treatmentObesity Reviews, 2000
- Novel AntipsychoticsThe Journal of Clinical Psychiatry, 1999